Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px
Document › Details

Immunicum AB. (2/3/17). "Press Release: Immunicum AB CEO to present at BIO CEO & Investor Conference". Gothenburg.

Organisations Organisation Immunicum AB (publ; First North Premier: IMMU.ST)
  Organisation 2 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization)
Products Product BIO CEO & Investor Conference 2017 New York
  Product 2 Intuvax®
Index term Index term Immunicum–BIO (US): investor conference, 201702 supply service Immunicum AB presents at BIO CEO & Investor Conference NY
Person Person de Sousa, Carlos (Immunicum 201610– CEO before Zealand Pharma + Nycomed/Takeda + Pfizer + Novartis + BBB Therapeutics)
     


Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid tumors, today announced that Carlos de Sousa, MD, CEO of Immunicum, will present at the BIO CEO & Investor Conference which will be held February 13-14, 2017 at the Waldorf Astoria, New York, NY.

Presentation Information:

Date: Monday, February 13, 2017
Time: 5:00 PM EST
Presentation Room: Duke of Windsor

For more information, please contact
Carlos de Sousa, CEO, Immunicum
Ph: +46 (0) 31 41 50 52
E-mail: info@immunicum.com


About Immunicum AB (publ)

Immunicum AB (First North Premier: IMMU.ST) is a clinical stage company developing novel immuno-oncology therapies against a range of solid tumors. The Company's lead compound, INTUVAX® is currently being evaluated in clinical trials for the treatment of kidney cancer, liver cancer and gastrointestinal stromal tumors. INTUVAX® was designed to combine the best of two worlds: a cost-effective cell-based (allogeneic) and off-the-shelf therapy that is capable of triggering a highly personalized and potentially long-lasting immune response against tumor cells throughout the body. www.immunicum.com

The Company's Certified Adviser is Redeye AB
Ph: + 46 8 545 013 31
www.redeye.se

   
Record changed: 2017-07-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Immunicum AB (publ; First North Premier: IMMU.ST)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px